SHOW TRANSCRIPT Novavax is looking for some 30,000 volunteers for its study. It will focus on high-risk older adults and volunteers from Black and Hispanic communities, which have been among the hardest-hit by the pandemic. Two-thirds of volunteers will get the vaccine; the rest will get a placebo.